verified SJR 0,297 · Q3 • database Scopus / SJR & Web of Science indexed

United Arab Emirates · Bentham Science Publishers

workspace_premium Q3 — Pharmacology lock Subscription

Current Radiopharmaceuticals

Current Radiopharmaceuticals is a journal indexed in SJR in Pharmacology and Radiology, Nuclear Medicine and Imaging with an H index of 35. It has an SJR impact factor of 0,297 and it has a best quartile of Q3. It has an SJR impact factor of 0,297.

ISSN: 1874-4710

Publisher: Bentham Science Publishers

Category: Pharmacology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,297 Q3

H-index 35

Acceptance rate pie_chart

37%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,297

H-index

Docs (year)

Docs 3y

115

Total refs

2235

Cites 3y

143

Citable 3y

105

Cites/Doc 2y

1.32

Ref/Doc

55.88

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Alternative method to determine Specific Activity of 177Lu by HPLC

What is Currently the Best Radiopharmaceutical for the Hybrid PET/CT Detection of Recurrent Medullary Thyroid Carcinoma?

Development and Evaluation of Liquid and Solid Lipid Based Drug Delivery Systems Containing Technetium-99m-Radiolabeled Alendronate Sodium

Detecting Growing Mammary Tumors with Monoclonal Antibodies Against Vascular Endothelial Growth Factor Receptor -3

CycloSal-dRFIB, a Thymidine Mimetic, Thymidine Kinase by-Pass Nucleoside Prodrug: Radioiodination, in vitro Cellular Uptake and Biodistribution in Murine Models

CT-MIBI-SPECT Fusion Imaging Combined with Gamma Probe for Minimally Invasive Radioguided Parathyroidectomy (MIRP)

Consequences of meta-stable 177mLu admixture in 177Lu for patient dosimetry

Comparison of Three Radiochemical Purity Control Methods of 99mTc-macroaggregated Albumin

Clinical Applications of Positron Emission Tomography (PET) Imaging in Medicine: Oncology, Brain Diseases and Cardiology

Chemical and Radiochemical Considerations in Radiolabeling with a-Emitting Radionuclides

Bismuth-213 and Actinium-225 -Generator Performance and Evolving Therapeutic Applications of Two Generator-Derived Alpha-Emitting Radioisotopes

Biological Evaluation of 99mTc-HYNIC-EDDA/tricine-(Ser)3-D4 Peptide for Tumor Targeting

SHOW MORE ARTICLES

An Optimised Radiolabel Procedure to Prepare 99mTc-Colloidal Rhenium Sulphide to Improve Radiochemical Purity

[11C]Meta-Hydroxyephedrine PET/CT

Alpha-Particle Microdosimetry

Acknowledgements to Reviewers:

Accurate assessment of whole-body retention for PRRT with 177Lu using paired measurements with external detectors

A Novel 99mTc-labeled Diphosphonic Acid as Potential Bone Seeking Agent: Synthesis and Biological Evaluation

A Brief Evaluation of Tumor Imaging in Mice with 99mTc-glucarate Including a Comparison with 18F-FDG

99mTc-labeling of Peptidomimetic Antagonist to Selectively Target avbeta3 Receptor-Positive Tumor: Comparison of PDA and EDDA as Co-Ligands

68Ga/64Cu PSMA Bio-Distribution in Prostate Cancer Patients: Potential Pitfalls for Different Tracers

64Cu Labeled AmBaSar-RGD2 for micro-PET Imaging of Integrin avbeta3 Expression

18F-FDG-PET/CT in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative 131I Whole Body Scan. It's Value Confirmed by a Bicentric Experience

123I-FP-CIT Brain SPECT Findings in Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency

FAQs

Current Radiopharmaceuticals has an SJR of 0,297 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Current Radiopharmaceuticals is 37%.

Current Radiopharmaceuticals

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Current Radiopharmaceuticals?

What is the APC / publication cost?

What is the acceptance rate?